Elixinol Wellness (AU:EXL) has released an update.
Invest with Confidence:
- Follow TipRanks' Top Wall Street Analysts to uncover their success rate and average return.
- Join thousands of data-driven investors – Build your Smart Portfolio for personalized insights.
Elixinol Wellness announced a significant change in the stock holdings of Director David Fenlon, who acquired 938,087 fully paid ordinary shares, increasing his stake to over 1.5 million shares. This acquisition was made through Director Fee Rights in lieu of cash, reflecting a strategic move by the company to align management interests with shareholders.
For further insights into AU:EXL stock, check out TipRanks’ Stock Analysis page.
